TANDEM DIABETES CARE INC·4

May 19, 7:14 PM ET

BLICKENSTAFF KIM D 4

4 · TANDEM DIABETES CARE INC · Filed May 19, 2022

Insider Transaction Report

Form 4
Period: 2022-05-17
BLICKENSTAFF KIM D
DirectorPRESIDENT AND CEO
Transactions
  • Exercise/Conversion

    Common Stock

    2022-05-17$9.00/sh+6,560$59,0408,452 total
  • Exercise/Conversion

    Common Stock

    2022-05-18+2,20510,657 total
  • Exercise/Conversion

    Common Stock

    2022-05-17$73.73/sh+13,562$999,872215,952 total(indirect: See Footnote)
  • Exercise/Conversion

    Stock Option

    2022-05-17$9.00/sh+6,560$59,0400 total
    Exercise: $9.00Common Stock (6,560 underlying)
  • Exercise/Conversion

    Warrant

    2022-05-17$73.73/sh+13,562$999,8720 total(indirect: See Footnote)
    Exercise: $73.73From: 2022-05-17Common Stock (13,562 underlying)
  • Exercise/Conversion

    Restricted Stock Unit

    2022-05-18+2,2050 total
    Common Stock (2,205 underlying)
  • Sale

    Common Stock

    2022-05-17$92.91/sh10,762$999,897205,190 total(indirect: See Footnote)
Footnotes (9)
  • [F1]Represents shares of common stock received upon exercise of a stock option award.
  • [F2]The transaction reflects the cashless exercise of warrants to purchase common stock, at an exercise price of $73.726. Pursuant to the terms of the warrant, the shares of common stock were sold at a price equal to the average of the closing prices of the shares over the 30-day period ending three days prior to the date on which the notice of exercise was received by the Issuer.
  • [F3]The securities are held by the Kim Blickenstaff Revocable Trust dated April 15, 2010.
  • [F4]The options vested as to twenty-five percent (25%) of the underlying shares on 5/17/2018, and the remaining shares vested in thirty-six (36) equal monthly installments thereafter, subject to the terms of Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan (the 2013 Plan).
  • [F5]The expiration date for these options is 10 years from the date of grant.
  • [F6]The expiration dates for these warrants are May 25, 2022 (2,712 shares), and July 3, 2022 (10,850 shares).
  • [F7]Awarded on May 18, 2021 pursuant to the 2013 Plan, as amended, and the agreements related thereto.
  • [F8]Each restricted stock (RSU) unit represents a contingent right to receive one share of common stock of the Company.
  • [F9]Shares will vest on the one year anniversary of the grant date, subject to the terms of the 2013 Plan.

Documents

2 files
  • 4
    wf-form4_165300203905899.xmlPrimary

    FORM 4

  • EX-24

    POA FOR KIM BLICKENSTAFF